Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane

Diabetologia

Volumn 37, Issue 3, 1994, Pages 313-320

  Tamsma, J T ^a   van den Born, J ^b   Bruijn, J A ^a   Assmann, K J M ^b   Weening, J J ^c,d   Berden, J H M ^b   Wieslander, J ^e   Schrama, E ^a   Hermans, J ^f   Veerkamp, J H ^b   Lemkes, H H P J ^a   van der Woude, F J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e Statens Seruminstitut ^*  (Denmark)

^f LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Diabetic nephropathy; extracellular matrix; glomerular basement membrane; heparan sulphate; heparan sulphate proteoglycan

Indexed keywords

HEPARAN SULFATE; PROTEOHEPARAN SULFATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; GLOMERULUS BASEMENT MEMBRANE; HUMAN; MALE; PRIORITY JOURNAL; PROTEINURIA;

AGED; BASEMENT MEMBRANE; COLLAGEN; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE; HEPARAN SULFATE PROTEOGLYCANS; HEPARITIN SULFATE; HUMANS; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; PROTEOGLYCANS;

EID: 0028297289     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/BF00398060     Document Type: Article

References (41)

1. Albuminuria reflects widespread vascular damage. The Steno hypothesis
2. Decreased de novo synthesis of glomerular proteoglycans in diabetes: biochemical and autoradiographic evidence
3. Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane
4. (35S) Sulphate incorporation into glomerular basement membrane glycosaminoglycan is decreased in experimental diabetes
5. 35Sglycosaminoglycan and 35S-glycopeptide metabolism by diabetic glomeruli and aorta
6. Decreased de novo synthesis of glomerular proteoglycan in diabetes: biochemical and autoradiographic evidence
7. Reduced synthesis of basement membrane heparan sulphate proteoglycan in streptozotocin-induced diabetic mice
8. Alterations in the basement membrane (heparan sulphate) proteoglycan in diabetic mice
9. Disturbances in glomerular basement membrane glycosaminoglycans in experimental diabetes
10. Release of glomerular heparan-35SO4 proteoglycan by heparin from glomeruli of streptozotocin-induced diabetic rats
11. Heparan sulphate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus
12. Characterization of novel sequences containing 3-O-sulphated glucosamine in glomerular basement membrane heparan sulphate and localization of sulphated disaccharides to a peripheral domain
13. Removal of sulphated (heparan sulphate) or non sulphated (hyaluron acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to 125I albumin
14. Increased permeability of the glomerular basement membrane to ferritine after removal of glycosaminoglycans (heparan sulphate) by enzyme digestion
15. Inhibition of rat mesangial cell growth by heparan sulphate
16. Heparin and glomerular epithelial cell-secreted heparin-like species inhibit mesangial-cell proliferation
17. A monoclonal antibody against GBM heparan sulphate induces an acute selective proteinuria in rats
18. Classification and diagnosis of diabetes
19. A strong correlation between glomerular filtration rate and filtration surface in diabetic nephropathy
20. Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes
21. Isolation and partial characterization of heparan sulphate proteoglycan from the human glomerular basement membrane
22. A histological study of the extracellular matrix during the development of glomerulosclerosis in murine chronic graft-versus-host disease
23. Characterization of monoclonal antibodies to the globular domain of collagen IV
24. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients
25. Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic complications
26. Constituents of the extracellular matrices in diabetic glomerulosclerosis
27. Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions
28. Effects of IGF-1 and glucose on protein and proteoglycan synthesis by human fetal mesangial cells in culture
29. Definition of diabetic renal disease in insulin-dependent diabetes mellitus based on renal function test
30. Microalbuminuria as a predictor of clinical nephropathy in insulin dependent diabetes mellitus
31. Predicting diabetic nephropathy in insulin-dependent patients
32. Incipient nephropathy in type 1 (insulin-dependent) diabetes
33. Structural-functional relationships in diabetic nephropathy
34. Pathogenesis of diabetic nephropathy: a hypothesis
35. Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats
36. Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes
37. Polyantigenic expansion of basement membrane constituents in diabetic nephropathy
38. Differential expression of basement membrane collagen chains in diabetic nephropathy
39. Phenotypic expression of collagen types in mesangial matrix of diabetic and nondiabetic rats
40. The eye and diabetes mellitus